Crosstalk among Oxidative Stress, Autophagy, and Apoptosis in the Protective Effects of Ginsenoside Rb1 on Brain Microvascular Endothelial Cells: A Mixed Computational and Experimental Study

Abstract

Objective

Brain microvascular endothelial cells (BMECs) were found to shift from their usually inactive state to an active state in ischemic stroke (IS) and cause neuronal damage. Ginsenoside Rb1 (GRb1), a component derived from medicinal plants, is known for its pharmacological benefits in IS, but its protective effects on BMECs have yet to be explored. This study aimed to investigate the potential protective effects of GRb1 on BMECs.

Methods

An in vitro oxygen-glucose deprivation/reperfusion (OGD/R) model was established to mimic ischemia-reperfusion (I/R) injury. Bulk RNA-sequencing data were analyzed by using the Human Autophagy Database and various bioinformatic tools, including gene set enrichment analysis (GSEA), Gene Ontology (GO) classification and enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, protein-protein interaction network analysis, and molecular docking. Experimental validation was also performed to ensure the reliability of our findings.

Results

Rb1 had a protective effect on BMECs subjected to OGD/R injury. Specifically, GRb1 was found to modulate the interplay between oxidative stress, apoptosis, and autophagy in BMECs. Key targets such as sequestosome 1 (SQSTM1/p62), autophagy related 5 (ATG5), and hypoxia-inducible factor 1-alpha (HIF-1α) were identified, highlighting their potential roles in mediating the protective effects of GRb1 against IS-induced damage.

Conclusion

GRbl protects BMECs against OGD/R injury by influencing oxidative stress, apoptosis, and autophagy. The identification of SQSTM1/p62, ATG5, and HIF-1α as promising targets further supports the potential of GRb1 as a therapeutic agent for IS, providing a foundation for future research into its mechanisms and applications in IS treatment.

References

[1] KeaneyJ, CampbellM. The dynamic blood-brain barrier. FEBS J, 2015, 282(21): 4067-4079

[2] SweeneyMD, ZhaoZ, MontagneA, et al.. Blood-brain barrier: From physiology to disease and back. Physiol Rev, 2019, 99(1): 21-78

[3] WongBW, MarschE, TrepsL, et al.. Endothelial cell metabolism in health and disease: Impact of hypoxia. EMBO J, 2017, 36(15): 2187-2203

[4] ObermeierB, DanemanR, RansohoffRM. Development, maintenance and disruption of the blood-brain barrier. Nat Med, 2013, 19(12): 1584-1596

[5] GongL, YinJ, ZhangY, et al.. Neuroprotective mechanisms of ginsenoside rb1 in central nervous system diseases. Front Pharmacol, 2022, 13: 914352

[6] HwangJY, ShimJS, SongMY, et al.. Proteomic analysis reveals that the protective effects of ginsenoside rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells. J Ginseng Res, 2016, 40(3): 278-284

[7] JiangN, WangK, ZhangY, et al.. Protective effect of ginsenoside rb1 against chronic restraint stress (CRS)-induced memory impairments in rats. Behav Brain Res, 2021, 405: 113146

[8] JiangZ, WangY, ZhangX, et al.. Preventive and therapeutic effects of ginsenoside rb1 for neural injury during cerebral infarction in rats. Am J Chin Med, 2013, 41(2): 341-352

[9] NiXC, WangHF, CaiYY, et al.. Ginsenoside rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke. Redox Biol, 2022, 54: 102363

[10] LiDW, ZhouFZ, SunXC, et al.. Ginsenoside rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection. Neural Regen Res, 2019, 14(10): 1814-1822

[11] Orellana-UrzúaS, RojasI, LíbanoL, et al.. Pathophysiology of ischemic stroke: Role of oxidative stress. Curr Pharm Des, 2020, 26(34): 4246-4260

[12] StarkR, GrzelakM, HadfieldJ. RNA sequencing: The teenage years. Nat Rev Genet, 2019, 20(11): 631-656

[13] ThindAS, MongaI, ThakurPK, et al.. Demystifying emerging bulk RNA-seq applications: The application and utility of bioinformatic methodology. Brief Bioinform, 2021, 22(6): bbab259

[14] GongL, ZhangD, DongY, et al.. Integrated bioinformatics analysis for identificating the therapeutic targets of aspirin in small cell lung cancer. J Biomed Inform, 2018, 88: 20-28

[15] GauthierJ, VincentAT, CharetteSJ, et al.. A brief history of bioinformatics. Brief Bioinform, 2019, 20(6): 1981-1996

[16] TomkinsJE, ManzoniC. Advances in protein-protein interaction network analysis for parkinson’s disease. Neurobiol Dis, 2021, 155: 105395

[17] FerreiraLG, Dos SantosRN, OlivaG, et al.. Molecular docking and structure-based drug design strategies. Mol Basel Switz, 2015, 20(7): 13384-13421

[18] PinziL, RastelliG. Molecular docking: Shifting paradigms in drug discovery. Int J Mol Sci, 2019, 20(18): 4331

[19] ZhouC, ZhongW, ZhouJ, et al.. Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells. Autophagy, 2012, 8(8): 1215-1226

[20] O’BoyleNM, BanckM, JamesCA, et al.. Open babel: An open chemical toolbox. J Cheminformatics, 2011, 3: 33

[21] EberhardtJ, Santos-MartinsD, TillackAF, et al.. AutoDock vina 1.2.0: New docking methods, expanded force field, and python bindings. J Chem Inf Model, 2021, 61(8): 3891-3898

[22] ElefantovaK, LakatosB, KubickovaJ, et al.. Detection of the mitochondrial membrane potential by the cationic dye JC-1 in l1210 cells with massive overexpression of the plasma membrane ABCB1 drug transporter. Int J Mol Sci, 2018, 19(7): 1985

[23] CossarizzaA, Baccarani-ContriM, KalashnikovaG, et al.. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolc arbocyanine iodide (JC-1). Biochem Biophys Res Commun, 1993, 197(1): 40-45

[24] PerelmanA, WachtelC, CohenM, et al.. JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis, 2012, 3(11): e430

[25] MendelsonSJ, PrabhakaranS. Diagnosis and management of transient ischemic attack and acute ischemic stroke: A review. JAMA, 2021, 325(11): 1088-1098

[26] AbdullahiW, TripathiD, RonaldsonPT. Blood-brain barrier dysfunction in ischemic stroke: Targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol, 2018, 315(3): C343-C356

[27] OrnatowskiW, LuQ, YegambaramM, et al.. Complex interplay between autophagy and oxidative stress in the development of pulmonary disease. Redox Biol, 2020, 36: 101679

[28] LevineB, KroemerG. Autophagy in the pathogenesis of disease. Cell, 2008, 132(1): 27-42

[29] LiZY, WuYF, XuXC, et al.. Autophagy as a double-edged sword in pulmonary epithelial injury: A review and perspective. Am J Physiol Lung Cell Mol Physiol, 2017, 313(2): L207-L217

[30] FilomeniG, DesideriE, CardaciS, et al.. Under the ROS: Thiol network is the principal suspect for autophagy commitment. Autophagy, 2010, 6(7): 999-1005

[31] Larson-CaseyJL, HeC, CarterAB. Mitochondrial quality control in pulmonary fibrosis. Redox Biol, 2020, 33: 101426

[32] YangN, GuanQW, ChenFH, et al.. Antioxidants targeting mitochondrial oxidative stress: Promising neuroprotectants for epilepsy. Oxid Med Cell Longev, 2020, 2020: 6687185

[33] ZhangL, WangK, LeiY, et al.. Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response. Free Radic Biol Med, 2015, 89: 452-465

[34] FuZJ, WangZY, XuL, et al.. HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury. Redox Biol, 2020, 36: 101671

[35] IchimuraY, WaguriS, SouY-S, et al.. Phosphorylation of p62 activates the keap1-nrf2 pathway during selective autophagy. Mol Cell, 2013, 51(5): 618-631

[36] BasitF, van OppenLM, SchöckelL, et al.. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells. Cell Death Dis, 2017, 8(3): e2716

[37] QinX, ZhangJ, WangB, et al.. Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells. Autophagy, 2021, 17(12): 4266-4285

[38] SchüttF, AretzS, AuffarthGU, et al.. Moderately reduced ATP levels promote oxidative stress and debilitate autophagic and phagocytic capacities in human RPE cells. Invest Ophthalmol Vis Sci, 2012, 53(9): 5354-5361

[39] YangNC, JengKCG, HoWM, et al.. ATP depletion is an important factor in DHEA-induced growth inhibition and apoptosis in BV-2 cells. Life Sci, 2002, 70(17): 1979-1988